(updated - 03 Feb 2012)
Stock Updates
Orchid Chemicals gets USFDA nod for Levofloxacin tablets
Disclaimer: Information presented on this site is a guide only. It may not necessarily be correct and is not intended to be taken as financial advice nor has it been prepared with regard to the individual investment needs and objectives or financial situation of any particular person. Stock quotes are believed to be accurate and correctly dated, but does not warrant or guarantee their accuracy or date.
Our site takes no responsibility for any investment decisions based on recommendations provided on website.
Google Adsense Ads are posted on every page of the website so visitors clicking on Ads and going to those links and carrying any financial deal is not at all related to to our website and any financial deal should be done on their own sole responsibility.
More News Follows
The Chennai based global pharma major, Orchid Chemicals & Pharmaceuticals has announced that it has received approval from the United States Food and Drugs Administration (USFDA) for its ANDA (Abbreviated New Drug Application) for Levofloxacin tablets.
The Levofloxacin tablets are in the 250 mg, 500 mg and 750 mg strengths.